WallStreetZenWallStreetZen

NASDAQ: NPCE
Neuropace Inc Stock Ownership - Who owns Neuropace?

Insider buying vs selling

Have Neuropace Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Martha MorrellChief Medical Officer2024-02-053,446$15.17
$52.28kSell
Martha MorrellChief Medical Officer2024-02-0214,143$15.07
$213.12kSell
Martha MorrellChief Medical Officer2024-02-01663$15.04
$9.97kSell
Martha MorrellChief Medical Officer2024-01-311,923$15.08
$28.99kSell
Martha MorrellChief Medical Officer2024-01-3011,262$15.10
$170.00kSell
Martha MorrellChief Medical Officer2024-01-251$15.00
$15.00Sell
Martha MorrellChief Medical Officer2024-01-24827$15.03
$12.43kSell
Martha MorrellChief Medical Officer2023-12-2713,300$10.12
$134.65kSell
Martha MorrellChief Medical Officer2023-12-26102$10.00
$1.02kSell
Martha MorrellChief Medical Officer2023-12-202,730$10.15
$27.70kSell

1 of 2

NPCE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NPCE insiders and whales buy or sell their stock.

NPCE Shareholders

What type of owners hold Neuropace Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Greg Shaw Garfield19.94%5,653,237$75.36MInsider
Kck Ltd19.73%5,593,773$74.56MInsider
URI Geiger15.64%4,432,948$59.09MInsider
Accelmed Partners Ii LP15.64%4,432,948$59.09MInsider
Orbimed Advisors LLC14.96%4,238,967$56.51MInsider
Evan Norton14.26%4,042,657$53.89MInsider
Orbimed Advisors LLC14.13%4,003,967$53.37MInstitution
Morgan Stanley8.68%2,460,716$32.80MInstitution
Soleus Capital Management LP8.58%2,433,168$32.43MInstitution
Nantahala Capital Management LLC4.14%1,173,677$15.65MInstitution

1 of 3

NPCE vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NPCE29.57%70.43%Net SellingNet Selling
ANIK84.64%15.36%Net SellingNet Selling
CVRX36.38%63.62%Net BuyingNet Buying
TCMD76.27%23.73%Net SellingNet Selling
BVS29.54%70.46%Net BuyingNet Selling

Neuropace Stock Ownership FAQ

Who owns Neuropace?

Neuropace (NASDAQ: NPCE) is owned by 44.77% institutional shareholders, 106.61% Neuropace insiders, and 0.00% retail investors. Greg Shaw Garfield is the largest individual Neuropace shareholder, owning 5.65M shares representing 19.94% of the company. Greg Shaw Garfield's Neuropace shares are currently valued at $77.05M.

If you're new to stock investing, here's how to buy Neuropace stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.